Cellosaurus logo
expasy logo

Cellosaurus MH [Human ovarian carcinoma] (CVCL_F845)

[Text version]
Cell line name MH [Human ovarian carcinoma]
Accession CVCL_F845
Resource Identification Initiative To cite this cell line use: MH [Human ovarian carcinoma] (RRID:CVCL_F845)
Comments Population: Japanese.
Doubling time: ~6.3 days (PubMed=8217948); 36 hours (PubMed=8375936).
Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
Disease Ovarian serous cystadenocarcinoma (NCIt: C7978)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 41Y
Category Cancer cell line
Publications

PubMed=8217948
Sasa H., Hisano A., Ishii K., Hirata J., Kikuchi Y., Nagata I., Senoo A., Aida S., Tamai S., Sugita M.
Establishment of a cisplatin-resistant human ovarian cancer cell line.
Hum. Cell 6:106-113(1993)

PubMed=8375936; DOI=10.1002/ijc.2910550332
Hirata J., Kikuchi Y., Kita T., Imaizumi E., Tode T., Ishii K., Kudoh K., Nagata I.
Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum(II) by 12-O-tetradecanoylphorbol-13-acetate and D,L-buthionine-S,R-sulphoximine.
Int. J. Cancer 55:521-527(1993)

PubMed=7844449
Ishii K., Kita T., Kudo K., Hisano A., Hirata J., Imaizumi E., Tode T., Kikuchi Y., Nagata I.
Circumvention of cisplatin resistant ovarian cancer cells by antiestrogens.
Nihon Sanka Fujinka Gakkai Zasshi 47:19-26(1995)

PubMed=17671176; DOI=10.1158/0008-5472.CAN-06-4567
Kikuchi R., Tsuda H., Kanai Y., Kasamatsu T., Sengoku K., Hirohashi S., Inazawa J., Imoto I.
Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
Cancer Res. 67:7095-7105(2007)

Cross-references
Cell line databases/resources CGH-DB; 339-2
Encyclopedic resources Wikidata; Q54905500
Polymorphism and mutation databases Cosmic; 931365
Entry history
Entry creation11-Feb-2013
Last entry update29-Jun-2023
Version number10